Connect with us

Health

Oral CBD Prevents Chemotherapy Induced Peripheral Neuropathy: Study Finds

mm

Published

 on

A study that was published in the official journal of the Multinational Association of Supportive Care in Cancer has shown that oral cannabidiol (CBD) is effective in preventing peripheral neuropathy that occurs following chemotherapy treatment. The study was conducted by researchers from the Department of Clinical Oncology and Palliative Care, Zealand University Hospital, Denmark.

Peripheral Neuropathy (PN) is a condition that affects nerves in the extremities (feet and hands) causing them to become weak, painful, and numb. Several factors may cause PN including diabetes, injuries, and exposure to toxins such as chemotherapy drugs. Common treatments for PN include the use of anticonvulsants (such as diazepam) antidepressants (such as amitriptyline) and pain medications (mild opioids). While these treatments help to relieve PN symptoms, they neither prevent it nor address the underlying issue. Those suffering from PN often find that they have to be on PN medication for extended durations and this of course presents the risk for addiction and other adverse effects.

What’s CBD and How Can it Help?

Cannabidiol, abbreviated as CBD, is one of the numerous phytocannabinoids that are present in cannabis. The therapeutic benefits of CBD in several areas have been confirmed by research. This includes the treatment of seizures, chronic pain, and social anxiety disorders among others.

A study was conducted to investigate the potential of CBD in preventing peripheral neuropathy in cancer patients receiving chemotherapy treatment (oxaliplatin or paclitaxel).

The patients were offered CBD at a dose of 150mg twice. The treatment started a day prior to chemotherapy treatment and was continued for 8 days. A control group (patients that did not receive CBD treatment) was also created.

At the end of the study, the researchers concluded that CBD attenuates the early symptoms of chemotherapy-induced PN without causing any major adverse effects.

What’s next?

While the neuroprotective benefits of CBD have been mentioned in the past, not much had been covered regarding its potential in the prevention or treatment of peripheral neuropathy.  From this new research, it’s apparent that CBD can offer hope to those suffering from chemotherapy-induced peripheral neuropathy. This finding warrants further research in the form of randomized clinical trials. Meanwhile, check out this interesting study that shows that CBD and THC have a greater benefit-safety profile compared to opioids used to manage chronic pain.

 

close

MyCannabis.com News!

We’d love to keep you updated with our latest cannabis news, industry interviews, and offers.

We don’t spam! Read our privacy policy for more info.

Lydia K. (Bsc. RN) is a cannabis writer, which, considering where you’re reading this, makes perfect sense. Currently, she is a regular writer for Mace Media. In the past, she has written for MyBud, RX Leaf & Dine Magazine (Canada), CBDShopy (UK) and Cannavalate & Pharmadiol (Australia). She is best known for writing epic news articles and medical pieces. Occasionally, she deviates from news and science and creates humorous articles. And boy doesn't she love that! She equally enjoys ice cream, as should all right-thinking people.

Posts/Pages Sidebar Form

Advertiser Disclosure: MyCannabis.com is committed to rigorous editorial standards to provide our readers with accurate reviews and ratings. We may receive compensation when you click on links to products we reviewed.

Educational & Medical Disclaimer: This information is for educational purposes only. We are not medical professionals, and no information on this website should be construed as medical advice. For more information please view our Educational & Medical Disclaimer.

Minimum Age: To use this website you must be the minimum age as allowed in your jurisdiction. USA visitors must be 21, visitors from Canada must be 18 or 19 years of age depending on the province. It is illegal for a person younger than this to use this website.